Skip to content

Optimization of diagnostic instruments in migraine

Optimization of diagnostic instruments in migraine - ODIN-migraine

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00022812
Enrollment
225
Registered
2020-08-10
Start date
2020-09-23
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

G43.0 G43.1 G43.3

Interventions

Group 1: The present study aims to expand the scope of behavioural medicine diagnostic instruments by developing (i) an measuring instrument to access „fear of migraine attacks“ and (ii) the german-sp

Sponsors

Psychologisches Institut; Johannes Gutenberg-Universität Mainz
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: • Existence of migraine disease according to the International Classification of Headache Diseases (ICHD-3): 1.1 migraine without aura, 1.2. migraine with aura, 1.3 chronic migraine • duration of disease at least 12 months

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

MeasureTime frame
Primary outcome is the self-developed questionnaire, that is assessing “fear of migraine attacks” (FAMI) and the German version of the Cogniphobia Scale for Headache Disorders (CS-HD-G). Previously socio-demographic (e.g. sex, relationship status, educational level) and migraine related anamnestic data (duration of disease, symptoms, treatment parameters) is collected. The collection of migraine related anamnestic data is used to verify the migraine diagnosis.

Secondary

MeasureTime frame
• To determine convergent validity, it will be asked for the following parameters: Headache days, number and duration of migraine attacks, number of days in the last month using medication for acute treatment. Additionally the following questionnaires will be applied: Migraine Disability Assessment Scale (MIDAS, German version, Agosti, Chrubasik & Kohlmann, 2008), Inventar zur Beeinträchtigung durch Kopfschmerzen (IBK, Bauer, Evers, Gralow & Husstedt, 1999),Headache Impact Test (HIT-6TM, German 6-item-shortversion, Gandek, Alacoque, Uzun, Andrew-Hobbs & Davis, 2003), Depressions-, Angst- und Stressskalen (DASS, Nilges & Essau, 2015), Pain Anxiety Symptom Scale (PASS-20, German 20-item-shortversion, Kreddig, Rusu, Burkhardt & Hasenbring, 2015), Generalized Anxiety Disorder Screener (GAD-7, German version, Löwe, 2015, Löwe et al., 2008), Headache Triggers Sensitivity and Avoidance Questionnaire (HTSAQ-SF-G, German shortversion, Caroli et al., 2019, Caroli et al., in press), Headache Management Self-Efficacy Scale (HMSE-G-SF/FKMS, German version, Graef, Rief, French, Nilges & Nestoriuc, 2015), Pain Vigilance and Awareness Questionnaire (PVAQ, German version, Lautenbacher et al., 2009) • To determine divergent validity the NEO-Five-Factor-Inventory (NEO-FFI-30, German 30-item-shortversion, Körner et al., 2008) will be applied.

Countries

Germany

Contacts

Public ContactTimo Klan

Psychologisches Institut; Johannes Gutenberg-Universität Mainz

migraenebefragung@uni-mainz.de+4961313939112

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026